Publications scientifiques

2676 PUBLICATIONS

ANNÉE

JOURNAL

PREMIER AUTEUR

TITRE

ANNÉE2023

JOURNALRadiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

PREMIER AUTEURGehin W

TITREDOSIMETRIC PREDICTIVE FACTORS FOR FACIAL NERVE PARALYSIS AFTER CYBERKNIFE® STEREOTACTIC RADIOTHERAPY FOR VESTIBULAR SCHWANNOMAS: A SINGLE INSTITUTION EXPERIENCE OF 88 PATIENTS.

ANNÉE2023

JOURNALJournal of contemporary brachytherapy

PREMIER AUTEURFaivre JC

TITREPrognostic factors of local control and progression-free survival in AJCC stages T1 and T2 cervical cancer patients treated with adjuvant brachytherapy after chemoradiotherapy.

ANNÉE2023

JOURNALBMC cancer

PREMIER AUTEURPivot X

TITREFinal analysis of the phase 3 randomized clinical trial comparing HD201 vs. referent trastuzumab in patients with ERBB2-positive breast cancer treated in the neoadjuvant setting.

ANNÉE2023

JOURNALPediatric blood & cancer

PREMIER AUTEURRaze T

TITREPAX-FOXO1 fusion status in children and adolescents with alveolar rhabdomyosarcoma: Impact on clinical, pathological, and survival features.

ANNÉE2023

JOURNALCellular & molecular immunology

PREMIER AUTEURViot J

TITRECD8 CD226 T cells in liver metastases dictate the prognosis of colorectal cancer patients treated with chemotherapy and radical surgery.

ANNÉE2023

JOURNALRadiation oncology (London, England)

PREMIER AUTEURKuntz L

TITREChanges in the characteristics of patients treated for brain metastases with repeat stereotactic radiotherapy (SRT): a retrospective study of 184 patients.

ANNÉE2023

JOURNALBreast cancer (Tokyo, Japan)

PREMIER AUTEURKada Mohammed S

TITREHER2-positive invasive lobular carcinoma: a rare breast cancer which may not necessarily require anti-HER2 therapy. A population-based study.

ANNÉE2023

JOURNALCancer medicine

PREMIER AUTEURAtsou KM

TITREFactors influencing access to specialised haematology units during acute myeloblastic leukaemia patient care: A population-based study in France.

ANNÉE2023

JOURNALInternational journal of pharmaceutics

PREMIER AUTEURFreis B

TITREBioconjugation studies of an EGF-R targeting ligand on dendronized iron oxide nanoparticles to target head and neck cancer cells.

ANNÉE2023

JOURNALCancers

PREMIER AUTEURThouvenin J

TITREComplete Response in Metastatic Clear Cell Renal Cell Carcinoma Patients Treated with Immune-Checkpoint Inhibitors: Remission or Healing? How to Improve Patients' Outcomes?

Retrouvez aussi

Unités de recherche, établissements

Projets de recherche

Publications scientifiques